TAGLN2’s role in breast cancer metastasis was examined through transwell migration, luciferase, and flow cytometry assays, as well as a mouse xenograft model, suggesting TAGLN2 acts as a tumor suppressor, and its loss may enhance breast cancer metastasis via activation of the ROS/NF-κB pathway [114]. This evidence concerns the gene NFKB1 and neoplasm.